-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Catalyst Pharmaceuticals, Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q3 2020 to Q2 2025.
- Catalyst Pharmaceuticals, Inc. Deferred Income Tax Assets, Net for the quarter ending June 30, 2025 was $50.7M, a 27.1% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)